The sample six is one of convenience. Given the limitations imposed by the time required for treatment planning and completing trials, the investigators estimate that one patient/month can be accrued and treated at each of the three centres. They anticipate 72 patients will be enrolled in the trial over a two year period. This will allow estimation of the late toxicity rate with reasonable precision.